Antinuclear antibody–positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis

…, S Dalprà, A Battagliese, S Verazza… - Arthritis & …, 2011 - Wiley Online Library
Objective We undertook this study to test the hypothesis that in the International League of
Associations for Rheumatology (ILAR) classification of juvenile idiopathic arthritis (JIA), …

Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score

…, A Frisina, MC Gallo, A Pistorio, S Verazza… - Annals of the …, 2014 - ard.bmj.com
Objective To determine cutoff values for defining the state of high disease activity (HDA) in
juvenile idiopathic arthritis (JIA) using the Juvenile Arthritis Disease Activity Score (JADAS). …

Parent and child acceptable symptom state in juvenile idiopathic arthritis

…, A Pistorio, N Solari, S Pederzoli, S Verazza… - The Journal of …, 2012 - jrheum.org
Objective. To explore the parent and child acceptable symptom state in juvenile arthritis (JA-PASS
and JA-CASS, respectively) and estimate the JA-PASS and JA-CASS cutoff values for …

Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised …

…, B Lattanzi, G Filocamo, S Verazza… - The Lancet, 2017 - thelancet.com
Background Little evidence-based information is available to guide the treatment of
oligoarticular juvenile idiopathic arthritis. We aimed to investigate whether oral methotrexate …

[HTML][HTML] Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept

S Verazza, S Davì, A Consolaro, F Bovis… - Pediatric …, 2016 - Springer
Background Data from routine clinical practice are needed to further define the efficacy and
safety of biologic medications in children with juvenile idiopathic arthritis (JIA). The aim of …

Rotavirus and the web: Analysis of online conversations in Italy during 2020

F Marchetti, S Verazza, M Brambilla… - Human Vaccines & …, 2022 - Taylor & Francis
Rotavirus is the most common cause of severe diarrhea among children worldwide. In 2017,
Italy included rotavirus vaccination in its National Immunization Program. The use of social …

[PDF][PDF] Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis

S Verazza, G Negro, D Marafon… - Clin Exp …, 2013 - clinexprheumatol.org
Several studies have examined effects of discontinuing treatment after clinical remission in
children with JIA. So far, only methotrexate and tumour necrosis factor α (TNF) inhibitors have …

[HTML][HTML] A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic …

…, B Schiappapietra, C Suffia, G Varnier, S Verazza… - Pediatric …, 2019 - Springer
Background To investigate the frequency of achievement of inactive disease (ID) in children
with juvenile idiopathic arthritis (JIA) treated with methotrexate (MTX) as the sole disease-…

A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis.

…, F Mongelli, S Pederzoli, S Verazza… - Clinical and …, 2021 - europepmc.org
Objectives To search for predictors of polyarticular extension in children with oligoarticular-onset
juvenile idiopathic arthritis (JIA) and to develop a prediction model for an extended …

Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis.

…, C Suffia, GC Varnier, S Verazza… - Clinical and …, 2020 - europepmc.org
Objectives To investigate the frequency of arthritis flare and factors affecting occurrence of
flare in children with juvenile idiopathic arthritis (JIA) who achieved inactive disease (ID) with …